Literature DB >> 8932384

Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein.

G Farmer1, P Friedlander, J Colgan, J L Manley, C Prives.   

Abstract

In addition to serving a role as a DNA binding-dependent transcriptional activator, p53 has been reported to repress a variety of promoters that lack p53 binding sites. Data from recent studies have suggested that this activity is mediated via an interaction between p53 and the TATA box binding protein (TBP). To investigate the functional relevance of this interaction in vivo, we have performed transient transfection assays in Drosophila Schneider cells. Wild-type p53 was found to repress expression from TATA box- but not initiator (Inr)-containing promoters activated by GAL4-VP16, GAL4-ftzQ or Sp1. A mutant p53(His175), defective in DNA binding and transcriptional activation, also inhibited TATA-dependent transcription activated by Sp1. However, p53 was unable to repress a basal TATA promoter stimulated by overexpression of TBP. Furthermore, overexpression of TBP failed to rescue the p53-mediated repression of activated transcription and a p53 mutant with its N-terminal TBP interaction domain intact, but defective in transcriptional activation and binding to TBP-associated factors (TAFs), was similarly defective in transcriptional repression. These data suggest that a p53-TBP interaction is not sufficient for transcriptional repression by p53 and that repression involves an interaction between p53 and other factors, such as TAFs, that are required for activated but not basal transcription. We suggest that p53-mediated repression results from squelching of a factor limiting for activated transcription from TATA- but not Inr-containing promoters.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932384      PMCID: PMC146238          DOI: 10.1093/nar/24.21.4281

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  70 in total

1.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

Review 2.  The tumor suppressor genes.

Authors:  A J Levine
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

Review 3.  The tumor suppressor p53.

Authors:  L A Donehower; A Bradley
Journal:  Biochim Biophys Acta       Date:  1993-08-23

Review 4.  TBP, a universal eukaryotic transcription factor?

Authors:  N Hernandez
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein.

Authors:  Y Shen; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.

Authors:  C Caelles; A Helmberg; M Karin
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

Review 7.  How loops, beta sheets, and alpha helices help us to understand p53.

Authors:  C Prives
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

8.  Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.

Authors:  X Chen; G Farmer; H Zhu; R Prywes; C Prives
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

9.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB.

Authors:  J A Goodrich; T Hoey; C J Thut; A Admon; R Tjian
Journal:  Cell       Date:  1993-11-05       Impact factor: 41.582

10.  Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.

Authors:  L D Kerr; L J Ransone; P Wamsley; M J Schmitt; T G Boyer; Q Zhou; A J Berk; I M Verma
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

View more
  22 in total

1.  SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Authors:  Jun Li; Mingjia Tan; Ling Li; Deepika Pamarthy; Theodore S Lawrence; Yi Sun
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

Authors:  C J Di Como; C Gaiddon; C Prives
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.

Authors:  K C Lee; A J Crowe; M C Barton
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  p53 regulates Ki-67 promoter activity through p53- and Sp1-dependent manner in HeLa cells.

Authors:  Mei-Juan Wang; Dong-Sheng Pei; Guo-Wei Qian; Xiao-Xing Yin; Qian Cheng; Lian-Tao Li; Hui-Zhong Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2011-05-25

5.  E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.

Authors:  Luis A Carvajal; Pierre-Jacques Hamard; Crystal Tonnessen; James J Manfredi
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

6.  Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Authors:  Yutaka Maeda; Wendy W Hwang-Verslues; Gang Wei; Takuya Fukazawa; Mary L Durbin; Laurie B Owen; Xuan Liu; Frances M Sladek
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

7.  Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter.

Authors:  Diederik van Bodegom; Wijnand Roessingh; Andrew Pridjian; Samir S El Dahr
Journal:  Biochim Biophys Acta       Date:  2010-04-11

Review 8.  MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.

Authors:  Demet Candas; Jian Jian Li
Journal:  Antioxid Redox Signal       Date:  2013-06-08       Impact factor: 8.401

9.  p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB.

Authors:  Diane Crighton; Annette Woiwode; Cheng Zhang; Nihar Mandavia; Jennifer P Morton; Lorna J Warnock; Jo Milner; Robert J White; Deborah L Johnson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.

Authors:  Matteo Rossi; Oleg N Demidov; Carl W Anderson; Ettore Appella; Sharlyn J Mazur
Journal:  Nucleic Acids Res       Date:  2008-11-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.